SynthesisAnnals of internal medicine2016

Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis.

Francesco Zaccardi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.